These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6529529)

  • 21. Interaction between metronidazole and drugs eliminated by oxidative metabolism.
    Jensen JC; Gugler R
    Clin Pharmacol Ther; 1985 Apr; 37(4):407-10. PubMed ID: 3979002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic drug monitoring of cyclosporin. Practical applications and limitations.
    Rodighiero V
    Clin Pharmacokinet; 1989 Jan; 16(1):27-37. PubMed ID: 2650953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin.
    Ducharme MP; Slaughter RL; Warbasse LH; Chandrasekar PH; Van de Velde V; Mannens G; Edwards DJ
    Clin Pharmacol Ther; 1995 Dec; 58(6):617-24. PubMed ID: 8529326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversed-phase high-performance liquid chromatography determination of cyclosporin in human blood.
    Sangalli L; Bonati M
    Ther Drug Monit; 1987 Sep; 9(3):353-7. PubMed ID: 3672581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is cyclosporin A an inhibitor of drug metabolism?
    Li G; Treiber G; Meinshausen J; Wolf J; Werringloer J; Klotz U
    Br J Clin Pharmacol; 1990 Jul; 30(1):71-7. PubMed ID: 2390433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of cyclosporin A measurement in whole blood by six different methods.
    Tjandra-Maga B; Verbesselt R; Scharpé S; Verkerk R; Lambert WE; Van Liedekerke B; De Leenheer A
    J Clin Chem Clin Biochem; 1990 Jan; 28(1):53-7. PubMed ID: 2313238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of low-dose prednisolone on cyclosporine pharmacokinetics in liver transplant recipients: radioimmunoassay with specific and non-specific monoclonal antibodies.
    Arnold JC; O'Grady JG; Tredger JM; Williams R
    Eur J Clin Pharmacol; 1990; 39(3):257-60. PubMed ID: 2257862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overestimation of cyclosporin-A levels, using the polyclonal and monoclonal RIA, increased due to the accumulation of crossreactive metabolites.
    Oosthuizen MM; Lambrechts H; Randleff-Rasmussen GM; Myburgh JA
    Transplant Proc; 1989 Feb; 21(1 Pt 1):895-7. PubMed ID: 2650292
    [No Abstract]   [Full Text] [Related]  

  • 29. Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction.
    De Mey C; Meineke I; Steinijans VW; Huber R; Hartmann M; Bliesath H; Wurst W
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S58-66. PubMed ID: 8793604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-dose kinetics of primidone in human subjects: effect of phenytoin on formation and elimination of active metabolites of primidone, phenobarbital and phenylethylmalonamide.
    Sato J; Sekizawa Y; Yoshida A; Owada E; Sakuta N; Yoshihara M; Goto T; Kobayashi Y; Ito K
    J Pharmacobiodyn; 1992 Sep; 15(9):467-72. PubMed ID: 1287181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of administration of phenytoin on the pharmacokinetics of isoxicam.
    Caillé G; Du Souich P; Larivière L; Vézina M; Lacasse Y
    Biopharm Drug Dispos; 1987; 8(1):57-61. PubMed ID: 3580513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the interaction between phenytoin and digoxin.
    Rameis H
    Eur J Clin Pharmacol; 1985; 29(1):49-53. PubMed ID: 4054206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of cyclosporin A in the serum of kidney transplant patients by rapid-flow fractionation and normal-phase high-performance liquid chromatography.
    Oka K; Hosoda K; Hirano T; Sakurai E; Kozaki M
    J Chromatogr; 1989 May; 490(1):145-54. PubMed ID: 2668308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of cyclosporin in man following a single oral dose: relationship to body fat content.
    Waters MR; Albano JD; Sharman VL; Raman GV
    Nephrol Dial Transplant; 1989; 4(1):71-4. PubMed ID: 2494602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporin-erythromycin interaction in renal transplant patients.
    Gupta SK; Bakran A; Johnson RW; Rowland M
    Br J Clin Pharmacol; 1989 Apr; 27(4):475-81. PubMed ID: 2655690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of intravenous methylprednisolone with oral cyclosporin.
    Ubhi CS; Woodhouse L; Giles GR
    Nephrol Dial Transplant; 1990; 5(5):376-8. PubMed ID: 2115629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An explanation of the noncorrespondence between assessment methods of cyclosporin.
    Randleff-Rasmussen GM; Oosthuizen MM; Myburgh JA
    Transpl Int; 1989 Dec; 2(4):181-6. PubMed ID: 2627259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporin: pharmacokinetics and detailed studies of plasma and erythrocyte binding during intravenous and oral administration.
    Legg B; Gupta SK; Rowland M; Johnson RW; Solomon LR
    Eur J Clin Pharmacol; 1988; 34(5):451-60. PubMed ID: 3203704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of cyclosporin A and of four metabolites in whole blood by high-performance liquid chromatography.
    Christians U; Zimmer KO; Wonigeit K; Sewing KF
    J Chromatogr; 1987 Jan; 413():121-9. PubMed ID: 3558661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition of antipyrine and phenytoin correlated with age and liver volume in man.
    Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L
    Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.